Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain - Test2 - elhamkhani - TriplyDB

Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain

Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain

http://www.wikidata.org/entity/Q24634125

about

Quantitative distribution and colocalization of non-muscle myosin light chain kinase isoforms and cortactin in human lung endothelium Treatment of Cancer Pain by Targeting Cytokines Emerging Relationships between Exercise, Sensory Nerves, and Neuropathic Pain Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain.Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy.Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions.Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities.Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.Short small-interfering RNAs produce interferon-α-mediated analgesia Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?Deciphering the modulation of gene expression by type I and II interferons combining 4sU-tagging, translational arrest and in silico promoter analysis.Interferon alpha inhibits spinal cord synaptic and nociceptive transmission via neuronal-glial interactions.Glia and pain: is chronic pain a gliopathy?Current evidence for a modulation of low back pain by human genetic variants.Activation of Both CB1 and CB2 Endocannabinoid Receptors Is Critical for Masculinization of the Developing Medial Amygdala and Juvenile Social Play Behavior.Dynamic regulation of the endocannabinoid system: implications for analgesia.The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease.Microglia and intractable chronic pain.Dynamic changes to the endocannabinoid system in models of chronic pain.Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids.Modulating the delicate glial-neuronal interactions in neuropathic pain: promises and potential caveats.Neuropathic pain: role of inflammation, immune response, and ion channel activity in central injury mechanisms.Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches.Vitamin B12-responsive neuropathies: A case series.Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?P2 receptors, microglial cytokines and chemokines, and neuropathic pain.Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium.Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia.Differential changes in GPR55 during microglial cell activation.Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism.Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels.Cytokine expression in the epidural space: a model of noncompressive disc herniation-induced inflammation Interferon-gamma potentiates NMDA receptor signaling in spinal dorsal horn neurons via microglia-neuron interaction.Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes.Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice.

P2860

Q24294241-BCF41385-9E49-409A-8D70-7A0C8B0885DC Q26779917-82EA646A-0D41-412F-A53B-E7241F39C77D Q28066195-F02E9D37-B66D-4E15-BA81-80FEB6947BFA Q30473707-BABF01F2-08D6-49B6-856D-3C05741DA299 Q33713080-E7F3786E-4667-4B81-9724-5167E43D5C39 Q34019573-E133A9A2-3AEE-40B9-8495-F41AFC38E9D6 Q34036011-D81181A6-6569-4B58-9A66-5944188D3BC7 Q34116825-2AFC0E14-B359-47CA-BA27-5D3252B813FF Q34993393-63318A01-4ACC-4167-97F1-884D8B170A54 Q35103574-376C46EF-EE3B-4AE0-9C1B-20375F130617 Q35641478-E08E5563-25B6-490A-B27F-9E8739A9E933 Q35829482-449BE6CF-87D8-4EE8-9A95-79D25EDD29B9 Q36347677-98CE6D71-E2E0-4EFB-A194-CA1E67217ACE Q36789308-423069A8-994E-4101-B5FC-E3A7BD580A96 Q37197803-8C865742-C4A3-49F6-9539-1EB09F413D53 Q37285609-E925288C-0A89-44F5-8F26-0B9CE0C02E2F Q37381399-ED795B9E-C717-41AB-9FE9-86B69204F74D Q37396519-EAF7CB16-0FC0-4823-814A-3F0906B08499 Q37610851-536F846C-A876-4921-855B-8CCFF532EBF0 Q37611106-13E2DDCA-9B75-4DDB-A293-72252F4F2C01 Q37988405-0C7C9AC5-09E0-4963-B9EE-8516FE322C13 Q38022210-CF8C093E-9DCC-4B2E-8154-65140F9A3028 Q38056398-11A07DC5-3937-4390-93CA-C5F1F244C88E Q38087533-8192BC3E-649D-4CB1-85DA-106ACCC80C45 Q38185075-06871CB8-13B1-480B-B1A3-ADA39DA225FE Q38211273-ED148449-02C9-4E88-9799-D52B3EBB8468 Q38247950-D39289B2-A868-4153-A923-27FD85FC60E1 Q38318458-1099C848-6895-4672-960C-F3EDD4BBFD12 Q38364736-439BDD56-54CA-4C4A-9301-9B9650F804AA Q38748394-5043F034-5F5C-40BF-A27A-ECF89D7EF51E Q38885571-64B58566-E504-4CDE-9E09-00A0A0529934 Q39077826-CC444D5E-8321-4053-9913-F3B8FE693185 Q39248070-D1843DDC-6899-4CC2-BE0F-095DA33B318F Q39847881-AA7F3FA2-0D0D-44D3-A2BD-E8A8D058D9DC Q40594444-430792CE-046F-4FF8-9BE7-A11517BBCBE5 Q41785702-92B8FC3E-A9F8-4D08-955A-794269AB34E3 Q41930415-C017FAC4-915B-4078-A48A-D1622E94CEB4 Q42155319-BD83D9CA-5956-4B06-899D-EF0D7373F28F Q48639392-6239E45A-1079-4DCB-8465-492527760F5E Q50668498-41AE49F5-34B0-4C37-9BC7-F95119546BF8

P2860

Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain

http://www.wikidata.org/entity/Q24634125

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Interferon-gamma is a critical ...... naling during neuropathic pain

@ast

Interferon-gamma is a critical ...... naling during neuropathic pain

@en

Interferon-gamma is a critical ...... naling during neuropathic pain

@nl

type

label

Interferon-gamma is a critical ...... naling during neuropathic pain

@ast

Interferon-gamma is a critical ...... naling during neuropathic pain

@en

Interferon-gamma is a critical ...... naling during neuropathic pain

@nl

prefLabel

Interferon-gamma is a critical ...... naling during neuropathic pain

@ast

Interferon-gamma is a critical ...... naling during neuropathic pain

@en

Interferon-gamma is a critical ...... naling during neuropathic pain

@nl

P1433

Q24634125-2B20399E-4770-4FCF-89A1-30BBCEA7571A

P1476

Q24634125-42DF0905-6E16-4EA3-833A-CC3CED476865

P2093

Q24634125-07B43F8C-50AE-48BA-9F77-07822E675D1A

Q24634125-31BD2CD9-E196-4C7A-BC84-2DC6BA9BD4BF

Q24634125-5EEEE4EB-A4AC-4EB7-91B0-71E2E556831A

Q24634125-723BC79E-CE81-4724-B18D-4586FDE49480

Q24634125-A33FB0AE-CCC1-43E4-8B9F-B39908436D49

Q24634125-A6598CF0-8F6D-478D-AE21-701A6FAB5345

Q24634125-AAD89C07-8A36-4DAC-9385-FFB5B86C4CFB

Q24634125-C4C7321A-3DB1-4357-9D32-5A95F7D02B4F

Q24634125-EC9056FE-2332-43DC-AB91-35F3BAB78A3C

Q24634125-EF84BF34-9B0C-44AC-8209-05C0C254639D

P2860

Q24634125-00D52D22-959A-414C-A631-CE63520E7750

Q24634125-0B4013E3-232F-47BA-A1C8-B4827A045000

Q24634125-0C7CD08D-0E87-42D4-ABFE-16B791F460BE

Q24634125-10A53637-8733-4ED8-AB15-A8365CBAF26F

Q24634125-157AB894-4794-461E-9854-B217098DB150

Q24634125-1D843C52-33F5-43EA-A885-2E4059E4AACB

Q24634125-201B32A7-823B-484E-B1EB-D7BCBED49420

Q24634125-25A08580-F0E5-4F8A-9ECA-9CAB3DDA065A

Q24634125-2B1F6475-BEB1-45D9-8672-EE40AA17F0E1

Q24634125-2B935316-D358-4521-957B-70F746820B8D

P304

Q24634125-B03A9D2F-A3A8-43DD-95C1-3CB0CE72E98A

P31

Q24634125-6A824DBA-D9B0-4250-82D4-E4C960B43890

P3181

Q24634125-A206F065-8587-4B53-B253-EC793BC0DD55

P356

Q24634125-F50B030A-81CE-4832-AF58-733A822B2D58

P407

Q24634125-14D7594A-1776-47E5-B3AD-4870C4DC2B58

P433

Q24634125-3A2ACB63-A071-4A78-B3C1-592CD3E465A0

P478

Q24634125-40ECF23C-2E2C-4F17-AD0E-E6B07C218B2C

P577

Q24634125-33BD31CF-BD4D-410B-9647-DA9742AEF468

P698

Q24634125-15EEB364-38D5-4544-A32C-D55D2455FCE9

P921

Q24634125-52C36D3B-8DE6-4996-A0E4-C45DA78DE3B6

Q24634125-6b48294b-11c8-4720-9a40-ef05d16bbccd

Q24634125-E96C0A6E-F31A-4B18-A97E-F9B299B1E27D

Q24634125-F0B4808A-35B9-4CFB-BBE8-2652D22FDB36

P932

Q24634125-CF6892BB-45DF-4F88-8640-D69820DD7916

P3181

P356

JNEUROSCI.3402-08.2008

P1433

Journal of Neuroscience

P1476

Interferon-gamma is a critical ...... naling during neuropathic pain

@en

P2093

Alfonso Gutierrez-Adan

http://www.w3.org/2001/XMLSchema#string

Andreas Zimmer

http://www.w3.org/2001/XMLSchema#string

Belén Pintado

http://www.w3.org/2001/XMLSchema#string

Elena Sanguino

http://www.w3.org/2001/XMLSchema#string

Ildiko Racz

http://www.w3.org/2001/XMLSchema#string

Jennifer Rehnelt

http://www.w3.org/2001/XMLSchema#string

Jorge Manzanares

http://www.w3.org/2001/XMLSchema#string

Josep E Baños

http://www.w3.org/2001/XMLSchema#string

Judith Alferink

http://www.w3.org/2001/XMLSchema#string

Miquel Martín

http://www.w3.org/2001/XMLSchema#string

P2860

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation

Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

The IFN gamma receptor: a paradigm for cytokine receptor signaling

Identification and functional characterization of brainstem cannabinoid CB2 receptors

Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis

Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense

Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain

Interferon gamma gene expression in sensory neurons: evidence for autocrine gene regulation

JASPAR: an open-access database for eukaryotic transcription factor binding profiles

P304

12136-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2250245

http://www.w3.org/2001/XMLSchema#string

P356

10.1523/JNEUROSCI.3402-08.2008

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19005078

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain

cannabinoid receptor

P932

3844840

http://www.w3.org/2001/XMLSchema#string